MBX Biosciences (MBX) Interest & Investment Income (2023 - 2026)
MBX Biosciences' Interest & Investment Income came in at $3.84 million for Q2 2026, up 60.2% from $2.39 million a year earlier and up 2.3% from the prior quarter.
Powered by 
Analysis
MBX Biosciences (MBX) Interest & Investment Income (2023 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, MBX Biosciences reported Interest & Investment Income of $13.63 million, up 42.9% year-over-year; for FY2025, it came in at $11.08 million, up 76.7% from FY2024.
- Going back by year, Interest & Investment Income was $6.27 million in FY2024 (+128.2%) and $2.75 million in FY2023.
- The Q2 2026 figure represents the highest quarterly Interest & Investment Income in data going back to Q3 2023.
- Year-over-year, Interest & Investment Income has increased for eight consecutive quarters, with growth averaging 100.4% over the last eight quarters.
- Over the past five years, the year-over-year growth in Interest & Investment Income ranged from 23.4% (Q4 2025) to 198.9% (Q2 2025).
- Business Quant data shows MBX's Interest & Investment Income at $3.75 million (Q1 2026), $3.73 million (Q4 2025) and $2.31 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 219.00 Mn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | - |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | 80.00 Mn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 120.60 Mn |
| 10 | MBX Biosciences | 2.57 Bn | 2.57 Bn | - | 3.84 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.84 Mn |
| Mar 31, 2026 | 3.75 Mn |
| Dec 31, 2025 | 3.73 Mn |
| Sep 30, 2025 | 2.31 Mn |
| Jun 30, 2025 | 2.39 Mn |
| Mar 31, 2025 | 2.65 Mn |
| Dec 31, 2024 | 3.02 Mn |
| Sep 30, 2024 | 1.47 Mn |
| Jun 30, 2024 | 801,000.00 |
| Mar 31, 2024 | 977,000.00 |
| Dec 31, 2023 | 1.15 Mn |
| Sep 30, 2023 | 783,000.00 |
API Access
MBX Biosciences Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=MBX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "MBX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=MBX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();